193 related articles for article (PubMed ID: 15914866)
1. No influence of amyloid-beta-degrading neprilysin activity on prion pathogenesis.
Glatzel M; Mohajeri MH; Poirier R; Nitsch RM; Schwarz P; Lu B; Aguzzi A
J Gen Virol; 2005 Jun; 86(Pt 6):1861-1867. PubMed ID: 15914866
[TBL] [Abstract][Full Text] [Related]
2. Protease resistance of infectious prions is suppressed by removal of a single atom in the cellular prion protein.
Leske H; Hornemann S; Herrmann US; Zhu C; Dametto P; Li B; Laferriere F; Polymenidou M; Pelczar P; Reimann RR; Schwarz P; Rushing EJ; Wüthrich K; Aguzzi A
PLoS One; 2017; 12(2):e0170503. PubMed ID: 28207746
[TBL] [Abstract][Full Text] [Related]
3. A receptor for infectious and cellular prion protein.
Martins VR
Braz J Med Biol Res; 1999 Jul; 32(7):853-9. PubMed ID: 10454744
[TBL] [Abstract][Full Text] [Related]
4. Prions amplify through degradation of the VPS10P sorting receptor sortilin.
Uchiyama K; Tomita M; Yano M; Chida J; Hara H; Das NR; Nykjaer A; Sakaguchi S
PLoS Pathog; 2017 Jun; 13(6):e1006470. PubMed ID: 28665987
[TBL] [Abstract][Full Text] [Related]
5. Sheep scrapie susceptibility-linked polymorphisms do not modulate the initial binding of cellular to disease-associated prion protein prior to conversion.
Rigter A; Bossers A
J Gen Virol; 2005 Sep; 86(Pt 9):2627-2634. PubMed ID: 16099922
[TBL] [Abstract][Full Text] [Related]
6. Cofactor and glycosylation preferences for in vitro prion conversion are predominantly determined by strain conformation.
Burke CM; Walsh DJ; Mark KMK; Deleault NR; Nishina KA; Agrimi U; Di Bari MA; Supattapone S
PLoS Pathog; 2020 Apr; 16(4):e1008495. PubMed ID: 32294141
[TBL] [Abstract][Full Text] [Related]
7. The Ninth Datta Lecture. Molecular biology of transmissible spongiform encephalopathies.
Weissmann C
FEBS Lett; 1996 Jun; 389(1):3-11. PubMed ID: 8682199
[TBL] [Abstract][Full Text] [Related]
8. Non-genetic propagation of strain-specific properties of scrapie prion protein.
Bessen RA; Kocisko DA; Raymond GJ; Nandan S; Lansbury PT; Caughey B
Nature; 1995 Jun; 375(6533):698-700. PubMed ID: 7791905
[TBL] [Abstract][Full Text] [Related]
9. Prion peptide 106-126 as a model for prion replication and neurotoxicity.
Singh N; Gu Y; Bose S; Kalepu S; Mishra RS; Verghese S
Front Biosci; 2002 Apr; 7():a60-71. PubMed ID: 11897566
[TBL] [Abstract][Full Text] [Related]
10. Cholesterol transporter ATP-binding cassette A1 (ABCA1) is elevated in prion disease and affects PrPC and PrPSc concentrations in cultured cells.
Kumar R; McClain D; Young R; Carlson GA
J Gen Virol; 2008 Jun; 89(Pt 6):1525-1532. PubMed ID: 18474570
[TBL] [Abstract][Full Text] [Related]
11. Normal host prion protein necessary for scrapie-induced neurotoxicity.
Brandner S; Isenmann S; Raeber A; Fischer M; Sailer A; Kobayashi Y; Marino S; Weissmann C; Aguzzi A
Nature; 1996 Jan; 379(6563):339-43. PubMed ID: 8552188
[TBL] [Abstract][Full Text] [Related]
12. Double-Edge Sword of Sustained ROCK Activation in Prion Diseases through Neuritogenesis Defects and Prion Accumulation.
Alleaume-Butaux A; Nicot S; Pietri M; Baudry A; Dakowski C; Tixador P; Ardila-Osorio H; Haeberlé AM; Bailly Y; Peyrin JM; Launay JM; Kellermann O; Schneider B
PLoS Pathog; 2015 Aug; 11(8):e1005073. PubMed ID: 26241960
[TBL] [Abstract][Full Text] [Related]
13. Prion-induced neuronal damage--the mechanisms of neuronal destruction in the subacute spongiform encephalopathies.
Giese A; Kretzschmar HA
Curr Top Microbiol Immunol; 2001; 253():203-17. PubMed ID: 11417136
[TBL] [Abstract][Full Text] [Related]
14. Structuring the puzzle of prion propagation.
Eghiaian F
Curr Opin Struct Biol; 2005 Dec; 15(6):724-30. PubMed ID: 16263262
[TBL] [Abstract][Full Text] [Related]
15. Biochemical fingerprints of prion infection: accumulations of aberrant full-length and N-terminally truncated PrP species are common features in mouse prion disease.
Pan T; Wong P; Chang B; Li C; Li R; Kang SC; Wisniewski T; Sy MS
J Virol; 2005 Jan; 79(2):934-43. PubMed ID: 15613322
[TBL] [Abstract][Full Text] [Related]
16. Infectivity-associated PrP(Sc) and disease duration-associated PrP(Sc) of mouse BSE prions.
Miyazawa K; Okada H; Masujin K; Iwamaru Y; Yokoyama T
Prion; 2015; 9(5):394-403. PubMed ID: 26555211
[TBL] [Abstract][Full Text] [Related]
17. Species barrier in prion diseases: a kinetic interpretation based on the conformational adaptation of the prion protein.
Kellershohn N; Laurent M
Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):539-45. PubMed ID: 9729459
[TBL] [Abstract][Full Text] [Related]
18. Prions: pathogenesis and reverse genetics.
Aguzzi A; Klein MA; Montrasio F; Pekarik V; Brandner S; Furukawa H; Käser P; Röckl C; Glatzel M
Ann N Y Acad Sci; 2000; 920():140-57. PubMed ID: 11193143
[TBL] [Abstract][Full Text] [Related]
19. Genetic and infectious prion diseases.
Prusiner SB
Arch Neurol; 1993 Nov; 50(11):1129-53. PubMed ID: 8105771
[TBL] [Abstract][Full Text] [Related]
20. High prion and PrPSc levels but delayed onset of disease in scrapie-inoculated mice heterozygous for a disrupted PrP gene.
Büeler H; Raeber A; Sailer A; Fischer M; Aguzzi A; Weissmann C
Mol Med; 1994 Nov; 1(1):19-30. PubMed ID: 8790598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]